2.6.12 and 2.6.13 PhEur 6
2.6.12 and 2.6.13 PhEur 6
01/2008:20612
In this general chapter, two sets of tests are presented. The first set presents the
reference methods to determine compliance with the monographs. Therefore, the
reference to this chapter in a monograph implies compliance with the first set of
tests, unless the use of the second test set has been authorized. The tests in
the second set also constitutes official methods of the European Pharmacopoeia, and can
to be referred to as such, especially in the authorization requests for sale. It is intended
replace the first set with the second set once the relevant monographs
have been reviewed. The second set presents the tests developed in cooperation with
the Japanese Pharmacopoeia and the United States Pharmacopoeia to meet the requirements
harmonized.
The tests described below will allow the quantitative enumeration of bacteria.
mesophilic and fungi that can grow under aerobic conditions.
Carry out the determination under the designed conditions to avoid accidental contamination of the
product that will be examined. The precautions taken to avoid contamination must be
such that it does not affect any microorganism that is revealed in the test. If the product that is going to
If the examined substance has antimicrobial activity, it must be adequately neutralized. If used
inactivators for this purpose, their effectiveness and non-toxicity against must be demonstrated
microorganisms.
Determine the total count of viable aerobes using the membrane filtration method or
by the plate counting method, as indicated in the monograph.
The Most Probable Number (MPN) method is reserved for bacterial counts when not
It has another method. The selection of a method can be based on factors such as the nature
of the product and the expected number of microorganisms. Any of the methods that are
selection must be properly validated.
1
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
Cuando se usa junto con el capítulo5.1.3o5.1.4, puede usarse el método de vertido en placa, el
surface dispersion method and membrane filtration method.
SAMPLE PREPARATION
Sampling plan. The sampling of the product must follow a well-defined sampling plan. The plan
Sampling will depend on factors such as the batch size, health risks associated with
unacceptable and highly contaminated products, the characteristics of the product and the level of
expected contamination. Unless otherwise indicated, use samples of 10 g or 10 mL
from the substance or preparation that is to be examined, taken with the mentioned precautions
previously. Select the sample(s) randomly from the bulk material or from the containers
available for the preparation. If necessary, to obtain the required amount, mix the
content of a sufficient number of containers to obtain each sample, depending on the
nature of the substance or preparation that is to be examined.
An example of a sampling plan applicable to products where the homogeneity concerning the
The distribution of microorganisms can be a problem, it is the class three sampling plan. In
In this case, five samples from each batch are taken and investigated separately. The three classes
they are recognized as:
acceptable samples, that is, samples that contain less demUFC (colony-forming units of
colonies) per gram or milliliter, where the limit specified in the relevant monograph is;
(ii) marginal samples, that is, with more than 10 mUFC per gram or less.
milliliter
(iii) defective samples, that is, those containing more than 10 mUFC per gram or milliliter.
2
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
Transdermal patches. Remove the protective covers ('peel off the backing') from ten patches of the
transdermal preparation, using sterile tweezers and placing them with the adhesive side facing up,
about sterile glass or plastic trays. If necessary, cover the adhesive surface with gauze
sterile (or monofilament polymer mesh type filter fabric), and transfer the ten patches to a
minimum volume of 500 mL of sodium chloride-peptone buffered solution pH 7.0 that
contain suitable inactivators, such as polysorbate 80 and/or lecithin. Shake vigorously the
Preparation for at least 30 minutes (Preparation A). Prepare another ten patches of the same.
put them in a minimum volume of 500 mL of medium D broth and shake vigorously
for at least 30 minutes (preparation B).
SAMPLE EXAMINATION
Membrane filtration. Use membrane filters that have a nominal pore size not
greater than 0.45 µm and whose effectiveness for retaining bacteria has been established. The type of
the filter material is selected in such a way that the bacteria retention efficiency is not affected
for the components of the sample to be investigated. The cellulose nitrate filters, for
for example, they can be used for aqueous, oily, and weakly alcoholic solutions and the filters of
cellulose acetate, for example, for strongly alcoholic solutions. The filtration device
It is designed to allow the transfer of the filter to the culture medium.
a. Pouring method in plate. Using Petri dishes of 9 cm in diameter, add to each dish
1 mL of the prepared sample as described in the 'Sample Preparation' section, and 15 mL
20 mL of a liquefied agar medium suitable for bacterial culture (such as medium B), or 15
20 mL of a suitable liquefied agar medium for the cultivation of fungi (such as medium C) to not
more than 45°C. If larger Petri dishes are used, the amount of agar increases.
corresponding. Prepare at least two Petri dishes for each dilution level for each medium.
3
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
Incubate the plates at 30°-35°C (20-25°C for fungi) for five days, unless stated otherwise.
time to obtain a reliable count. Select the plates that correspond to a dilution and
that show the largest number of colonies less than 300 (100 colonies for the fungi). Use
the arithmetic mean of the counts and calculate the number of colony-forming units per
gram or milliliter.
b. Surface dispersion method. Using Petri dishes with a diameter of 9 cm, add 15-
20 mL of an appropriate liquefied agar medium for bacterial culture (such as medium B), or 15-
20 mL of a suitable liquefied agar medium for fungal cultivation (such as medium C) not exceeding
at 45°C for each Petri dish and allow to solidify. If larger Petri dishes are used, increase the
volume of agar accordingly. Dry the plates, for example in a flow hood.
in laminar air or in an incubator. Dispense a measured volume of no less than 0.1 mL of the
sample prepared as described in the section "Sample Preparation" on the surface
of the medium. Use at least two Petri dishes for each medium and dilution level. For incubation
and the calculation of the number of colony-forming units, proceed as described for the
plate casting method.
The precision and accuracy of the most probable number (MPN) method is lower than that of the method
of membrane filtration or plate counting methods. Results are not obtained
reliable, particularly for the enumeration of fungi. For these reasons, the NMP method
it is reserved for the enumeration of bacteria in situations where no other method is available. If
the use of the method is justified, proceed as follows.
4
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
5
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
Cultivate the test bacterial strains separately in containers that have a liquid medium.
suitable (like half A broth) at 30°-35°C for 18 to 24 hours. Culture the test strains of
fungi separately on an appropriate agar medium (such as medium C without antibiotics) at 20-25°C
for 48 hours for Candida albicans, at 20-25°C for 7 days for Aspergillus niger.
INTERPRETATION OF RESULTS
The bacterial count will be considered equal to the average number of colony-forming units.
found in the agar medium B. The fungal count will be considered equal to the average number.
of colony-forming units found in the agar medium C. The total count of
viable aerobes is the sum of bacterial count and fungal count as described
previously. If there is evidence that the same types of microorganisms grow in both
means, this can be corrected. If the count is done using the most number method
likely, the calculated value is the bacterial count.
If a sampling plan such as the class three sampling plan is used, proceed as follows:
Calculate the total viable aerobic count separately for each of the five samples. The
Substance or preparation passes the test if the following conditions are met:
6
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
none of the total counts of individual viable aerobes exceeds the prescribed limit in a
a factor of ten or more (that is, "unacceptable samples");
(ii) no more than two of the individual total viable aerobic counts are within the limit
prescribed and ten times its limit (that is, no more than two 'marginal samples').
The recommended solutions and culture media are described in the general chapter 2.6.13.
1. INTRODUCTION
The tests described below will allow for the quantitative enumeration of bacteria
mesophilic and fungi that can grow in aerobic conditions.
The methods do not apply to products that contain viable microorganisms such as
active ingredients.
2. GENERAL PROCEDURES
Carry out the determination under the designed conditions to avoid microbial contamination
extrinsic to the product that is going to be examined. The precautions taken to avoid the
contamination must be such that it does not affect any microorganism that is revealed in the test.
If surfactants are used for sample preparation, their absence must be demonstrated.
de toxicidad para los microorganismos y su compatibilidad con los inactivadores usados.
3. ENUMERATION METHODS
Use the membrane filtration method or the plate count method, as indicated. The
the most probable number (MPN) method is generally the least accurate method for the
microbial counts, however, for some product groups with a very low bioburden,
this may be the most appropriate method.
The selection of the method is based on factors such as the nature of the product and the required limit of
microorganisms. The selected method must allow for the testing of a sample size
7
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
[Link] CONSIDERATIONS
The ability of the test to detect microorganisms in the presence of must be established.
product that is going to be tested.
The suitability must be confirmed when a change is introduced in the execution of the test or in the
product, which could affect the outcome of the test.
To verify the test conditions, a negative control is performed using the diluent.
selected instead of the test preparation. There should be no growth of microorganisms.
Test each batch of semi-prepared material and each batch of semi-prepared from material.
dehydrated or of the described ingredients.
Inoculate portions/plates of digested casein soy broth and digested casein soy agar
with a small number (no more than 100 UFC) of the microorganisms indicated in the Table
2.6.12.-2, using a separate half-plate portion for each microorganism. Inoculate the
Sabouraud-dextrose agar plates with a small number (no more than 100 CFU) of the
microorganisms indicated in Table 2.6.12:2, using a separate plate of medium for each
one. Incubate under the conditions described in Table 2.6.12:2.
For solid media, the growth obtained should not differ by a factor greater than 2 from
of the calculated value for a standardized inoculum. For a freshly prepared medium, growth
The occurrence of microorganisms happens in a manner comparable to the previously obtained growth with
8
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
a batch of media that has been previously tested and approved. The liquid media are suitable if an occurs
Microorganism growth clearly visible comparable to the previous growth
obtained with a previously tested and approved batch of half.
Fluids or solids in aerosol form. Aseptically transfer the product to a device with a filter.
from the membrane or to a sterile container to carry out the subsequent sampling. Use the content
total defined number of measured doses from each tested container.
Transdermal patches. Remove the protective cover ('take off the lining') of the patches.
transdermal patches, and place them with the adhesive side facing up, on sterile glass or
plastic. Cover the adhesive surface with a sterile porous material, such as gauze, to
prevent the patches from sticking to each other, and transfer the patches to an appropriate volume of
selected diluent containing inactivators such as polysorbate 80 and/or lecithin. Shake the
Preparation vigorously for at least 30 minutes.
9
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
good apply
sporulation
10
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
4-5-2. Inoculation and dilution. Add to the prepared sample as described above.
(4-5-1) and in a control (without the test material included) a sufficient volume of the suspension
microbial to obtain an inoculum of no more than 100 CFU. The volume of the suspension of
The inoculum should not exceed 1 percent of the volume of the diluted product.
In order to demonstrate acceptable microbial recovery from the product, the factor must be used.
lowest possible dilution of the prepared sample for the test. When this is not possible due to
a la actividad antimicrobiana o a una solubilidad pobre, se deben desarrollar protocolos apropiados.
If the growth inhibition by the sample cannot be avoided by other means, the aliquot of the
Microbial suspension can be added after neutralization, dilution, or filtration.
If growth is inhibited (reduction by a factor greater than 2), modify the procedure to
the particular counting test, to ensure the validity of the results. The modification of
the procedure may include, for example, (1) an increase in the volume of the diluent or medium
of cultivation, (2) incorporation of specific or general neutralizing agents in the diluent, (3)
membrane filtration, or (4) a combination of the previous measures.
If an adequate neutralizing method cannot be found, it can be assumed that the failure to
isolation of the inoculated microorganism is attributable to the microbicidal activity of the product. This
Information serves to indicate that it is unlikely for the product to be contaminated with the given species.
of microorganisms. However, it is possible that the product only inhibits some of the
microorganisms specified here, but does not inhibit other microorganisms not included among
11
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
the test strains or for which the latter are not representative. So, perform the test
with the highest dilution factor compatible with microbial growth and the criterion of
specific acceptance.
4-5-4. Recovery of microorganisms in the presence of the product. For each microorganism
list, separate tests are conducted. Only the microorganisms of the strain are counted.
added test.
4-5-4-1. Membrane filtration. Use membrane filters that have a pore size
nominal no greater than 0.45 µm. The type of filter material is selected in such a way that the
efficiency to retain bacteria is not affected by the components of the sample that is going to be
investigated. For each listed microorganism, a membrane filter is used.
Dry the plates, for example in a laminar flow hood or in an incubator. For each
Microorganism listed in Table 2.6.12.-2, at least 2 Petri dishes are used. Dispense a volume
measured no less than 0.1 mL of the prepared sample as described in 4-5-1 to 4-5-3 on the
surface of the medium. Incubate and count as indicated in 4-5-4-2-1.
4-5-4-3. Most Probable Number (MPN) Method. The accuracy and precision of the MPN method is
smaller than that of the membrane filtration method or the plate count method. They are obtained
unreliable results particularly for the counting of fungi. For these reasons, the method
NMP is reserved for the numbering of TAMC in situations where no other is available.
method. If the use of the method is justified, proceed as follows:
12
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
Incubate all tubes at 30 – 35ºC for no more than 3 days. If the reading of the results is
difficult or uncertain due to the nature of the product that is going to be examined, subcultivar in the
same broth, or in agar of digested casein from soy, for 1 - 2 days at the same temperature, and
use these results. Using Table 2.6.12:4, determine the most probable number of
microorganisms per gram or milliliter of the examined product.
When the suitability of the membrane filtration method or the counting method is verified in
plate, an average count of the test microorganisms must be obtained that does not differ in a
factor greater than 2 with respect to the control value defined in 4-5-2 in the absence of the product.
When verifying the suitability of the NMP method, the value calculated from the inoculum must be
within the 95 percent confidence limits of the results obtained with the control.
If the criteria indicated above cannot be met for one or more of the
microorganisms tested with any of the described methods, to test the product is used
the method and testing conditions that most closely meet the criteria.
The amount to be tested can be reduced for active substances that will be formulated in
the following conditions: the quantity per dosage unit (for example, tablet, capsule, injection)
is less than or equal to 1 mg, or the amount per gram or milliliter (for preparations that are not presented
in dosage units) is less than 1 mg. In these cases, the amount to be tested is not
less than the amount present in 10 units of dosage or 10 g or 10 mL of the product.
For materials used as active substances, where the sample quantity is limited or the
the batch size is extremely small (i.e., less than 1000 mL or 1000 g), the amount
the sample must be 1 percent of the lot, unless prescribed or justified and authorized.
smaller amount.
For products where the total number of entities in a batch is less than 200 (for example,
samples used in clinical studies), the sample size can be reduced to 2 units, or 1
unit if the size is less than 100.
Select the sample(s) at random from the bulk material or from the available containers of the
preparation. To obtain the required amount, mix the contents of a sufficient number of
containers to obtain the sample.
13
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
14
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
[Link] filtration
Use a filtration device designed to allow the transfer of the filter to the medium. Prepare the
sample using a method that has proven to be suitable as described in section 4, and
transfer the appropriate amount to each of 2 membrane filters, and filter immediately.
Wash each filter following the procedure that has proven to be appropriate.
For the determination of TAMC, transfer one of the membrane filters to the surface of the agar.
from soy casein digested. For the determination of TYMC, transfer the other membrane to the
Sabouraud-dextrose agar surface. Incubate the casein digest soy agar plate at 30
-35ºC for 3-5 days, and the Sabouraud-dextrose agar plate at 20-25ºC for 5-7 days.
Calculate the number of CFU per gram or per milliliter of product.
When examining transdermal patches, filter 10 percent of the volume of the preparation.
described in 4-5-1, separately through each of 2 sterile membrane filters. Transfer
one membrane to the digested casein soy agar for TAMC, and the other membrane to the agar of
Sabouraud dextrose for TYMC.
Prepare the sample using the method that has proven to be suitable, as described in the
section 4. Prepare at least 2 Petri dishes for each dilution level for each medium. Incubate the
casein digested soy agar plates at 30-35ºC for 3-5 days, and the agar plates
Sabouraud dextrose at 20-25 °C for 5-7 days. Select the plates that correspond to a
dilution given and showing the highest number of colonies less than 250 for TAMC and 50 for
TYMC. Obtain the arithmetic average of the counts by culturing method, and calculate the
UFC numbers per gram or per milliliter of product.
Prepare the sample using a method that has proven to be suitable, as described in the
section 4. Prepare at least 2 Petri dishes for each medium and each dilution level. For the
incubation and calculation of the number of CFU proceed as described for the counting method in
plate.
Prepare and dilute the sample using a method that has proven to be suitable, as described.
In section 4. Incubate all tubes at 30-35ºC for 3-5 days. If necessary, carry out a
subculture using the procedure that has proven to be suitable. Record for each level of
dilution the number of tubes that show microbial growth. Determine the most
probable microorganisms per gram or milliliter of examined product, based on the
Table 2.6.12.-4.
15
European Pharmacopoeia 6.0 2.6.12 Microbiological examination of non-sterile products
The total count of aerobic microbes (TAMC) is considered to be equal to the number of CFU.
found using casein digested soy agar; if fungal colonies are detected in this
half, these colonies are counted as part of the TAMC. The total combined count of
Yeasts/fungi (TYMC) is considered to be equal to the number of CFU found using agar.
Sabouraud dextrose; if bacterial colonies are detected in this medium, they are counted as
part of the TYMC. When is it expected that the TYMC will exceed the acceptance criterion due to the
bacterial growth, Sabouraud-dextrose agar containing antibiotics can be used. If the
count is carried out using the NMP method, the calculated value is the TAMC.
The recommended solutions and means are described in chapter general 2.6.13 (in the section
B, harmonized method).
16
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
01/2008:20613
corrected 6.0
In this general chapter, two sets of tests are presented. The first set presents the
reference methods to determine compliance with the monographs. Therefore, the
Reference to this chapter in a monograph implies compliance with the first set of
tests, unless the use of the second set of tests has been authorized. The tests in
the second set also constitutes official methods of the European Pharmacopoeia, and can
they are referred to as such, especially in the requests for authorization for sale. It is intended
replace the first set with the second set once the relevant monographs
have been reviewed. The second set presents the tests developed in cooperation with
the Japanese Pharmacopoeia and the United States Pharmacopoeia to meet the requirements
harmonized.
1
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
Table 2.6.13.-1
Results for each quantity of product
Probable number of bacteria
0.1 g of 0.01 g of 0.001 g of
per gram of product
0.1 mL 0.01 mL 0.001 mL
+ + + More than 103
+ + – Less than 103and more than 102
+ – – Less than 102and more than 10
– – – Less than 10
Salmonella
Prepare the product to be examined as described in the general method 2.6.12, but using
liquid medium A instead of the peptone-sodium chloride solution buffered at pH 7.0,
homogenize and incubate at 35-37 °C for 18-24 h. Transfer 1 mL of the enrichment medium
a 10 mL of liquid medium I and incubate at 41-43 °C for 18-24 h. Make subcultures in at least
2 different solid media, chosen from the following: agar medium J, agar medium K and medium
Incubate at 35-37 °C for 18-72 hours. The appearance of cultures with the following
characteristics indicate the possible presence of bacteria of the genus Salmonella:
in the middle of agar J: well-developed, colorless colonies,
in the middle of agar K: well-developed, red colonies that may or may not present centers
blacks,
in the middle of agar L: small colonies, transparent, colorless or with a coloration that can
vary from pink to opaque white, often surrounded by a pink area
or red.
Transfer a few suspicious colonies separately to the agar medium M in tubes, using
inoculation on the surface and in depth. The presence of salmonella is confirmed.
provisionally if in the inoculation in depth, but not in the one carried out on the surface, it
produces a color change from red to yellow, generally accompanied by gas formation,
with or without hydrogen sulfide production in the agar. A confirmation can be made
definitively through appropriate biochemical and serological reactions. The product to be examined goes
la prueba si no se observan colonias del tipo descrito o si las reacciones bioquímicas y serológicas
confirmation ones are negative.
2
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
Pseudomonas aeruginosa
Prepare the product to be examined as described in the general method 2.6.12 and use 10 mL or
the amount corresponding to 1 g or 1 mL to inoculate 100 mL of liquid medium A, homogenize
Incubate at 35-37 °C for 18-48 hours. Perform subcultures on an agar N medium plate.
incubate them at 35-37 °C for 18-72 h. The substance to be examined passes the test if it is not detected.
growth of microorganisms. If colonies formed by Gram-negative bacilli appear,
transfer part of the morphologically different isolated colonies to liquid medium A and incubate at
41-43 °C for 18-24 h. The sample passes the test if no growth occurs at 41-43 °C.
For the transdermal patch test, filter 50 mL of preparation A as described in the
general method 2.6.12 through a sterile membrane filter, place the membrane in 100 mL
from liquid medium A and incubate at 35-37 °C for 18-48 h. After incubation, spread onto
the N agar medium.
Staphylococcus aureus
Prepare the product to be examined as described in the general method 2.6.12 and use 10 mL or
the amount corresponding to 1 g or 1 mL to inoculate 100 mL of liquid medium A, homogenize
Incubate at 35-37 °C for 18-48 hours. Perform subcultures on an agar medium plate O and
incubate them at 35-37 °C for 18-72 h. The appearance of black colonies of Gram-positive cocci, at
small surrounded by a transparent area, constitutes an indication of the presence of S. aureus.
confirmation can be made through appropriate biochemical reactions such as tests of the
coagulase and deoxyribonuclease. The product being examined passes the test if no observations are made
colonies of the type described in the agar medium O, or if the confirmation biochemical reactions
they are negative.
3
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
detection of S. aureus, P. aeruginosa, E. coli, and Salmonella, in the presence and absence of the product
to be examined. A positive result must be obtained for the respective microorganisms.
Clostridia
The tests described below have various purposes. The first method is used
for products from which it is essential to exclude contamination by clostridia, what it does
necessary to demonstrate their absence. Generally in such products, the total count of
the microorganisms is low. The second method is a semi-quantitative test for Clostridium
perfringensy is intended for products in which the level of contamination with this species
constitutes a quality criterion.
Clostridia test
Prepare the product to be examined as described in the general method 2.6.12. Take 2
equal portions of the preparation, corresponding to 1 g or 1 mL of the product to be examined.
Heat 1 portion to 80 °C for 10 minutes and cool it quickly. Do not heat the other portion.
Transfer 10 mL of each of the homogenized portions to 2 containers (38 mm × 200 mm) or to
other suitable containers that hold 100 mL of medium P. Incubate under anaerobic conditions at
35-37 °C for 48 h. After this incubation, perform subcultures from each tube in Q medium.
with gentamicin, incubating under anaerobic conditions at 35-37 °C for 48 h. If not detected
microorganism growth, the product passes the test.
If there were growth, to re-cultivate each of the types of colonies formed.
in medium Q, without gentamicin, and incubate both under aerobic and anaerobic conditions. The
observation of growth exclusively anaerobic of Gram-positive bacilli (with or without formation of
endospores), which give a negative catalase reaction, indicates that it is Clostridium spp. If
It is necessary to compare the appearance of the colonies growing on both plates, using the
catalase test to eliminate Bacillus spp, aerobic or facultatively anaerobic, which give
positive said reaction. This test can be applied to isolated colonies on agar, or also
indirectly prior to transferring the bacteria to glass slides, depositing on the
cells a drop of diluted hydrogen peroxide solution R. The formation of gas bubbles
indicates that the catalase reaction is positive.
2. Clostridium perfringens count
Prepare the product to be examined as described in the general method 2.6.12 and prepare dilutions.
1:100 and 1:1000 in peptone-sodium chloride solution buffered at pH 7.0. Determine the
most probable number of bacteria as described for the count of aerobic microorganisms
total viable in 2.6.12, using culture medium R in tubes or in other suitable containers that
have a small Durham bell. Mix with the minimal possible agitation and incubate at
45.5-46.5 °C for 24-48 h. Containers that show blackening due to the formation
of iron(II) sulfide, as well as abundant gas in the Durham bell (at least 1/10 of the
Volume) indicate the presence of Cl. perfringens. Estimate the most probable number of Cl.
perfringens using Table 2.6.13.-2.
Controls
Use the following strains:
For method 1: Clostridium sporogenes, for example ATCC 19404 (NCTC 532) or CIP 79.3,
For method 2: Clostridium perfringens, for example ATCC 13124 (NCIMB 6125,
NCTC 8237, CIP 103 409.
If necessary, combine with Cl. sporogenes to verify selectivity and the conditions.
anaerobes.
4
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
5
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
6
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
Medium F agar (agar with crystal violet, neutral red and bile, with glucose)
Yeast extract 3.0 g
Pancreatic hydrolyzed gelatin 7.0 g
Biliary sales 1.5 g
Monohydrate lactose 10.0 g
Sodium chloride 5.0 g
Monohydrate glucose 10.0 g
If 15.0 g
Neutral red 30 mg
Crystal violet 2 mg
Purified water 1000 mL
Adjust the pH so that after heating it is 7.4 ± 0.2.
Heat to boiling; a autoclave should not be used.
7
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
8
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
Medium of L agar (agar with sucrose, monohydrate lactose, phenol red, and brilliant green)
Peptones (from meat and casein) 10.0 g
Yeast extract 3.0 g
Sodium chloride 5.0 g
Monohydrate lactose 10.0 g
Sucrose 10.0 g
If 20.0 g
Phenol red 80 mg
Bright green 12.5 mg
Purified water 1000 mL
Heat to boiling for 1 minute.
Adjust the pH so that after sterilization it is 6.9 ± 0.2.
Immediately before use, sterilize by heating.
in an autoclave at 121 °C for 15 min, cool to 50 °C
and transfer to Petri dishes.
9
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
10
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
Neutralizing agents
Neutralizing agents can be used to neutralize the activity of agents.
antimicrobials. They can be added to the peptone-sodium chloride solution buffered at pH 7.0,
preferably before sterilization. If used, their efficacy and absence must be demonstrated.
of toxicity against microorganisms.
A typical neutralizing liquid has the following composition:
Polysorbate 80 30 g
Lecithin (egg) 3g
Histidine hydrochloride 1g
Peptone (from meat or casein) 1g
Sodium chloride 4.3 g
Potassium dihydrogen phosphate 3.6 g
Dihydrated sodium hydrogen phosphate 7.2 g
Purified water 1000 mL
Sterilize by heating in an autoclave at 121 °C for 15 minutes.
If the solution does not have enough neutralization capacity,
the concentration of Polysorbate 80 or lecithin can be increased.
Alternatively, the neutralizing agents mentioned in Table 2.6.13.-3 can be added.
11
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
B. HARMONIZED METHOD
1. INTRODUCTION
The tests described here will allow for the determination of the absence, or the limited presence, of
specific microorganisms that can be detected under the described conditions.
The tests have been designed primarily to determine whether a substance or preparation
meets an established specification for microbiological quality. If used for such
purposes, follow the instructions outlined below, including the number of
samples to be taken, and interpret the results as indicated later.
2. GENERAL PROCEDURES
If surfactants are used in the sample preparation, their effectiveness must be demonstrated.
absence of toxicity for microorganisms and compatibility with the inactivators used,
as described in chapter general 2.6.12 (in section B, Harmonized method).
12
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
Use standardized stable suspensions of test strains, or prepare them as indicated further.
forward. Crop maintenance techniques of the planting batch are used (batch systems
sowing), in such a way that the viable microorganisms used for inoculation correspond
no more than five passes from the original master planting lot.
3-1-1. Aerobic microorganisms. Cultivate each test bacterial strain separately in broth.
casein and soy digested agar or casein and soy digested agar at a temperature of 30-35ºC
for a period of 18 to 24 hours. Grow the test strain of Candida albicans separately.
in Sabouraud dextrose or in Sabouraud Dextrose Broth at a temperature of 20-25ºC for
a period of 2 to 3 days.
- Staphylococcus aureus, for example ATCC 6538, NCIMB 9518, CIP 4.83 or NBRC 13276;
- Pseudomonas aeruginosa, for example ATCC 9027, NCIMB 8626, CIP 82.118 or NBRC
13275
- Escherichia coli, for example ATCC 8739, NCIMB 8545, CIP 53.126 or NBRC 3972;
- Salmonella enterica subsp. enterica serotype Typhimurium, for example ATCC 14028 or, as
an alternative, Salmonella enterica subspecies enterica serotype Abony, for example NBRC
100797, NCTC 6017 or CIP 80.39;
- Candida albicans, for example ATCC 10231, NCPF 3179, IP 48.72 or NBRC 1594.
[Link] CONTROL
To verify the test conditions, perform a negative control using the diluent.
selected instead of test preparation. There should be no growth of microorganisms.
13
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
Test each batch of ready-to-use medium and each batch of medium prepared from medium.
dried or of the ingredients.
Verify the appropriate properties of the relevant media as indicated in Table 2.6.13.-1.
Testing the properties of growth promotion, solid media: carry out the method of
surface area, inoculating each of the plates with a small number (no more than 100
UFC) of the appropriate microorganism. Incubate at the specified temperature for a time not
greater than the shorter period indicated in the test. There is a growth of microorganisms
comparable to that obtained previously with a batch of half analyzed and previously approved.
Test of inhibitory properties, liquid or solid media: Inoculate the appropriate medium with
at least 100 UFC of the appropriate microorganism. Incubate at the specified temperature for a
no less time than the greater period indicated in the test. No growth occurs of
test microorganism.
For a specific product, if the antimicrobial activity concerning the microorganism for
which indicates that the test cannot be neutralized, it is assumed that the inhibited microorganism does not
will be present in the product.
14
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
4. PRODUCT TESTING
15
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
[Link] test
4-1-3-1. Selection and subculturing. Inoculate appropriate amounts of Mossel broth for
enrichment of enterobacteria with the preparation as indicated in 4-1-1 and/or dilutions of the
same that contain respectively 0.1 g; 0.01 g and 0.001 g (or 0.1 mL; 0.01 mL and 0.001 mL) of the
product to be examined. Incubate at a temperature of 30-35ºC for a period of 24 to 48 hours.
Subculture each of the crops on a red violet bile glucose agar plate. Incubate at a
temperature of 30-35ºC for a period of 18 to 24 hours.
4-1-3-2. Interpretation. The growth of colonies constitutes a positive result. Indicate the
the smallest amount of the product that produces a positive result and the largest amount that produces a
negative result. Based on Table 2.6.13.-2, determine the probable number of bacteria.
[Link] COLI
4-2-2. Selection and subculture. Shake the container, transfer 1 mL of digested casein and soy broth.
100 mL of MacConkey Broth and incubate at 42 - 44ºC for 24 - 48 hours. Subculture on a plate of
Incubate MacConkey at 30-35ºC for 18 - 72 h.
4-2-3. Interpretation. The growth of colonies indicates the possible presence of E. coli. This is
confirm through identification tests.
The product passes the test if there are no colonies present or if the identification tests are
negatives.
16
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
[Link]
4-3-2. Selection and subculturing. Transfer 0.1 mL of digested casein and soy broth to 10 mL of
Rappaport Vassiliadis broth for Salmonella enrichment, and incubate at 30-35ºC for 18-
24 h. Subculture on xylose agar plates, lysine, deoxycholate. Incubate at 30-35ºC for 18-48 h.
The product passes the tests if colonies of the described types are not present, or if they are
confirmatory identification tests are negative.
4-4-1. Sample preparation and prior incubation. Prepare a sample using a dilution.
1 in 10 of no less than 1 g of the product to be examined as described in the general chapter
2.6.12 (in section B, Harmonized method), and use 10 mL or the amount corresponding to 1 g or
1 mL to inoculate an adequate amount (determined as described in 3-4) of broth
casein and soy digerido and mix. When analyzing transdermal patches, filter the volume
corresponding sample of a patch of the preparation described in 4-5-1 in the general chapter
2.6.12 through a sterile membrane filter, and place in 100 mL of digested casein broth and
soy. Incubate at a temperature of 30-35ºC for a period of 18 to 24 hours.
4-4-2. Selection and subculturing. Subculture on a cetrimide agar plate and incubate at 30-35ºC.
during 18-72 h.
4-4-3. Interpretation. The growth of colonies indicates the possible presence of P. aeruginosa. This
it is confirmed through identification tests.
The product passes the test if there are no colonies present or if the confirmatory tests of
Identification is negative.
[Link] AUREUS
17
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
4-5-2. Selection and subculturing. Subculture on a mannitol salt agar plate and incubate at 30-35ºC.
during 18-72 h.
The product passes the tests if colonies of the described types are not present, or if the
Confirmatory identification tests are negative.
[Link]
4-6-2. Selection and subculture. Transfer 10 mL of each mixed portion to 2 containers (38 mm
x 20 mmm or other suitable containers) that contain 100 mL of reinforced medium for
clostridia. Incubate under anaerobic conditions at a temperature of 30-35ºC for 48 hours.
After incubation, perform subcultures from each tube onto Columbia agar, and incubate in
anaerobic conditions at a temperature of 30-35ºC for 48 hours.
The product passes the tests if there are no colonies of the described types present, or if the
Confirmatory identification tests are negative.
4-7-1. Sample preparation and prior incubation. Prepare the product to be examined as
is described in chapter general2.6.12 (in section B, Harmonized method), and use 10 mL or the
an amount corresponding to no less than 1 g or 1 mL to inoculate 100 mL of Sabouraud broth
Dextrose, and mix. Incubate at 30-35ºC for 3 - 5 days.
4-7-2. Selection and subculturing. Subculture on a Sabouraud dextrose agar plate and incubate at
30-35ºC for 24 - 48 h.
4-7-3. Interpretation. The growth of colonies may indicate the presence of C. albicans. This is
confirm through identification tests.
The product passes the tests if such colonies are not present or if the tests
Identification confirmatory tests are negative.
18
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
It has been found that the following solutions and culture media are satisfactory for the
purposes for which they are prescribed in the microbial contamination test in the
Pharmacopoeia. Other means can be used if they have growth-promoting properties and
similar inhibitors.
Phosphate buffer solution pH 7.2. Prepare a mixture of stock buffer solution and
purified water (1:800 V/V), and sterilize.
19
Farmacopea Europea 6.0 2.6.13 Microbiological examination of non-sterile products
If Sabouraud dextrose
Dextrose 40.0 g
Mixture of peptic digested animal tissue and 10.0 g
pancreatic digest of casein (1:1)
If 15.0 g
Purified water 1000 mL
Adjust the pH so that after sterilization it is 5.6 ± 0.2 at 25ºC. Sterilize in a
autoclave using a validated cycle.
Agar dextrose
Potato infusion 200 g
Dextrose 20.0 g
If 15.0 g
Purified water 1000 mL
Adjust the pH so that after sterilization it is 5.6 ± 0.2 at 25ºC.
Esterilizar en un autoclave usando un ciclo validado.
20
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
MacConkey broth
Pancreatic gelatin digested 20.0 g
Lactose monohydrate 10.0 g
Dehydrated ox tongue 5.0 g
Bromcresol purple 10 mg
Purified water 1000 mL
Adjust the pH so that after sterilization it is 7.3 ± 0.2 at 25ºC.
Sterilize in an autoclave using a validated cycle.
If MacConkey
Pancreatic gel digestion 17.0 g
Peptones (from meat and casein) 3.0 g
Lactose monohydrate 10.0 g
Sodium chloride 5.0 g
Biliary sales 1.5 g
If 13.5 g
Neutral red 30.0 mg
Violet crystal 1 mg
Purified water 1000 mL
Adjust the pH so that after sterilization it is 7.1 ± 0.2 at 25ºC.
Boil for 1 minute with constant stirring, and sterilize in an autoclave using a validated cycle.
21
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
Xylose 3.5 g
L-Lysine 5.0 g
Lactose monohydrate 7.5 g
Sucrose 7.5 g
Cloruro de sodio 5.0 g
Yeast extract 3.0 g
Phenol red 80 mg
If 13.5 g
Sodium deoxycholate 2.5 g
Sodium thiosulfate 6.8 g
Ammonium ferric citrate 0.8 g
Purified water 1000 mL
Adjust the pH so that after heating it is 7.4 ± 0.2 at 25ºC. Heat to boiling,
cool to 50ºC and pour into Petri dishes. Do not heat in an autoclave.
If cetrimide
Pancreatic gel digested 20.0 g
Magnesium chloride 1.4 g
Potassium sulfate 10.0 g
Cetrimide 0.3 g
If 13.6 g
Purified water 1000 mL
Glycerol 10.0 mL
Heat to boiling for 1 minute with stirring. Adjust the pH so that after the
sterilization should be at 7.2 ± 0.2 at 25ºC. Sterilize in an autoclave using a validated cycle.
22
European Pharmacopoeia 6.0 2.6.13 Microbiological examination of non-sterile products
If mannitol salt
Pancreatic casein digested 5.0 g
Digested peptic of animal tissue 5.0 g
Meat extract 1.0 g
DMannitol 10.0 g
Sodium chloride 75.0 g
If 15.0 g
Phenol red 0.025 g
Purified water 1000 mL
Heat to boiling for 1 minute while stirring. Adjust the pH so that after the
sterilization should be at 7.4 ± 0.2 at 25ºC. Sterilize in an autoclave using a validated cycle.
If Columbia
Pancreatic casein digested 10.0 g
Peptic meat digest 5.0 g
Pancreatic heart digested 3.0 g
Yeast extract 5.0 g
Corn starch 1.0 g
Sodium chloride 5.0 g
If, according to the gelling capacity 10.0 - 15.0 g
Agua purificada 1000 mL
Hydrate the agar and dissolve by heating until boiling and stirring constantly. If it were
necessary, adjust the pH so that after sterilization it is 7.3 ± 0.2 at 25ºC. Sterilize in
an autoclave using a validated cycle. Allow to cool to 45-50ºC; add sulfate if necessary
of gentamicin corresponding to 20 mg of base gentamicin, and pour into Petri dishes.
23